These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 39126093)

  • 1. Biological Evaluation of Dinuclear Platinum(II) Complexes with Aromatic
    Luković D; Franich AA; Živković MD; Rajković S; Stojanović B; Gajović N; Jurišević M; Pavlović S; Simović Marković B; Jovanović M; Stojanović BS; Pavlović R; Jovanović I
    Int J Mol Sci; 2024 Aug; 25(15):. PubMed ID: 39126093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Drug discovery research in in-vivo antitumor-active azolato-bridged dinuclear Pt(II) complexes].
    Komeda S
    Yakugaku Zasshi; 2012; 132(3):253-9. PubMed ID: 22382827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New minor groove covering DNA binding mode of dinuclear Pt(II) complexes with various pyridine-linked bridging ligands and dual anticancer-antiangiogenic activities.
    Franich AA; Živković MD; Ilić-Tomić T; Đorđević IS; Nikodinović-Runić J; Pavić A; Janjić GV; Rajković S
    J Biol Inorg Chem; 2020 May; 25(3):395-409. PubMed ID: 32162071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, cytotoxic activity and DNA interaction studies of new dinuclear platinum(ii) complexes with an aromatic 1,5-naphthyridine bridging ligand: DNA binding mode of polynuclear platinum(ii) complexes in relation to the complex structure.
    Konovalov B; Živković MD; Milovanović JZ; Djordjević DB; Arsenijević AN; Vasić IR; Janjić GV; Franich A; Manojlović D; Skrivanj S; Milovanović MZ; Djuran MI; Rajković S
    Dalton Trans; 2018 Oct; 47(42):15091-15102. PubMed ID: 30303498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of series of diazine-bridged dinuclear platinum(II) complexes through in vitro toxicity and molecular modeling: correlation between structure and activity of Pt(II) complexes.
    Senerovic L; Zivkovic MD; Veselinovic A; Pavic A; Djuran MI; Rajkovic S; Nikodinovic-Runic J
    J Med Chem; 2015 Feb; 58(3):1442-51. PubMed ID: 25551180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemistry, antiproliferative activity and low nephrotoxicity of 3,5-diacetyl-1,2,4-triazol bis(4N-thiosemicarbazone) ligands and their platinum(II) complexes.
    Matesanz AI; Joie C; Souza P
    Dalton Trans; 2010 Aug; 39(30):7059-65. PubMed ID: 20571622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of antitumor azolato-bridged dinuclear platinum(ii) complexes with in vivo antitumor efficacy and unique in vitro cytotoxicity profiles.
    Komeda S; Takayama H; Suzuki T; Odani A; Yamori T; Chikuma M
    Metallomics; 2013 May; 5(5):461-8. PubMed ID: 23608770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syntheses, crystal structures, and biological evaluations of new dinuclear platinum(ii) complexes with 1,2,4-triazole derivatives as bridging ligands.
    Wang J; Li X; Yuan C; Su F; Wu YB; Lu L; Zhu M; Xing S; Fu X
    Dalton Trans; 2021 Apr; 50(13):4527-4538. PubMed ID: 33725030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization, modes of interactions with DNA/BSA biomolecules and anti-tumor activity of newly synthesized dinuclear platinum(II) complexes with pyridazine bridging ligand.
    Zornić S; Simović Marković B; Franich AA; Janjić GV; Jadranin MB; Avdalović J; Rajković S; Živković MD; Arsenijević NN; Radosavljević GD; Pantić J
    J Biol Inorg Chem; 2024 Feb; 29(1):51-73. PubMed ID: 38099936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of geometric isomerism on the anticancer property of new platinum complexes with glycine derivatives as asymmetric N, O donate ligands against human cancer.
    Kadivar D; Eslami Moghadam M; Notash B
    Spectrochim Acta A Mol Biomol Spectrosc; 2024 Dec; 322():124809. PubMed ID: 39018672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photoactivatable Cell-Selective Dinuclear trans-Diazidoplatinum(IV) Anticancer Prodrugs.
    Shi H; Romero-Canelón I; Hreusova M; Novakova O; Venkatesh V; Habtemariam A; Clarkson GJ; Song JI; Brabec V; Sadler PJ
    Inorg Chem; 2018 Nov; 57(22):14409-14420. PubMed ID: 30365308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers.
    Serebryanskaya TV; Yung T; Bogdanov AA; Shchebet A; Johnsen SA; Lyakhov AS; Ivashkevich LS; Ibrahimava ZA; Garbuzenco TS; Kolesnikova TS; Melnova NI; Gaponik PN; Ivashkevich OA
    J Inorg Biochem; 2013 Mar; 120():44-53. PubMed ID: 23305964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticancer platinum(II) complexes bearing N-heterocycle rings.
    Facchetti G; Rimoldi I
    Bioorg Med Chem Lett; 2019 Jun; 29(11):1257-1263. PubMed ID: 30935797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dinuclear Platinum(II) Complexes with Bone-Targeting Groups as Potential Anti-Osteosarcoma Agents.
    Zhang Z; Wang X; Luo C; Zhu C; Wang K; Zhang C; Guo Z
    Chem Asian J; 2017 Jul; 12(13):1659-1667. PubMed ID: 28556606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of chirality on the anticancer activity of Pt(II) and Pt(IV) complexes containing 1
    Papadia P; Barbanente A; Ditaranto N; Hoeschele JD; Natile G; Marzano C; Gandin V; Margiotta N
    Dalton Trans; 2021 Nov; 50(43):15655-15668. PubMed ID: 34673864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monofunctional platinum(II) complexes with potent tumor cell growth inhibitory activity: the effect of a hydrogen-bond donor/acceptor N-heterocyclic ligand.
    Margiotta N; Savino S; Gandin V; Marzano C; Natile G
    ChemMedChem; 2014 Jun; 9(6):1161-8. PubMed ID: 24799414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, cytotoxicity, induction of apoptosis, and interaction with DNA of dinuclear platinum(II) complexes.
    Xu G; Gao C; Gou S; Cao Z
    ChemMedChem; 2012 Nov; 7(11):2004-9. PubMed ID: 23015351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetically Inert Platinum (II) Complexes for Improving Anticancer Therapy: Recent Developments and Road Ahead.
    Panda TR; Patra M
    ChemMedChem; 2024 Sep; 19(17):e202400196. PubMed ID: 38757478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morpholine or methylpiperazine and salicylaldimine based heteroleptic square planner platinum (II) complexes: In vitro anticancer study and growth retardation effect on E. coli.
    Rahman FU; Ali A; Khan IU; Duong HQ; Yu SB; Lin YJ; Wang H; Li ZT; Zhang DW
    Eur J Med Chem; 2017 May; 131():263-274. PubMed ID: 28334655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic activity and influence on acetylcholinesterase of series dinuclear platinum(II) complexes with aromatic nitrogen-containing heterocyclic bridging ligands: Insights in the mechanisms of action.
    Bondžić AM; Žakula JJ; Korićanac LB; Keta OD; Janjić GV; Đorđević IS; Rajković SU
    Chem Biol Interact; 2022 Jan; 351():109708. PubMed ID: 34666020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.